secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001104659-24-063396
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Collegium shareholders re-elect all eight directors and approve say-on-pay at 2024 annual meeting
--------------------------------------------------------------------------------

- All eight director nominees re-elected; each received >98% of votes cast (For range: 25.4M-28.4M).
- Advisory vote on executive compensation passed with 28,311,783 For (98.8% of votes cast).
- Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 30,106,217 For.
- Annual meeting held May 16, 2024; 31,059,529 shares present (94.9% of outstanding shares).
- Broker non-votes were 2,360,841 on director and say-on-pay; 837,061 on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465924063396/0001104659-24-063396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465924063396/tm2414882d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-063396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer